Potent CD4+ T-cell epitope P30 enhances HER2/neu-engineered dendritic cell-induced immunity against Tg1-1 breast cancer in transgenic FVBneuN mice by enhanced CD4+ T-cell-stimulated CTL responsesYufeng Xie, J Xiang, Khawaja Ashfaque Ahmed et al.|Cancer Gene Therapy|2013Cited by 17